Egetis Therapeutics AB (PDPHF) Q2 2023 Earnings Report
2 Followers
PDPHF Q2 2023 EPS Results
- Actual EPS
- -$0.03
- Consensus EPS
- -$0.03
- Beat/Miss
- Missed by -$0.00
- One Year Ago EPS
- -$0.02
PDPHF Q2 2023 Revenue Results
- Actual Revenue
- $607.60K
- Expected Revenue
- $541.07K
- Beat/Miss
- Beat by +$66.53K
- YoY Revenue Growth
- +26.61%
Earnings Announcement Details
- Quarter
- Q2 2023
- Date
- 08/22/2023
- Time
- TBA
- Conference Call
- Tuesday, August 22, 2023
Q2 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
PDPHF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 06, 2026 | 2026 (Q3) | -0.02- | -0.02 | ― | |
| Aug 21, 2026 | 2026 (Q2) | -0.02-0.03 | -0.02 | -17.62% (-0.00) | |
| Apr 29, 2026 | 2026 (Q1) | -0.02-0.02 | -0.02 | -41.18% (-0.01) | |
| Feb 26, 2026 | 2025 (Q4) | -0.03-0.03 | -0.03 | 2.58% (+0.00) | |
| Nov 25, 2025 | 2025 (Q3) | -0.02-0.02 | -0.03 | 18.73% (+0.01) | |
| Aug 21, 2025 | 2025 (Q2) | -0.02-0.02 | -0.02 | 12.13% (+0.00) | |
| Apr 30, 2025 | 2025 (Q1) | -0.02-0.02 | -0.03 | 34.62% (+0.01) | |
| Feb 26, 2025 | 2024 (Q4) | -0.03-0.03 | -0.03 | 5.20% (+0.00) | |
| Nov 08, 2024 | 2024 (Q3) | -0.03-0.03 | -0.04 | 18.21% (+0.01) | |
| Aug 22, 2024 | 2024 (Q2) | -0.03-0.02 | -0.03 | 24.84% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
